Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

Reproducible quantification of cardiac sympathetic innervation using graphical modeling of carbon-11-meta-hydroxyephedrine kinetics with dynamic PET-CT imaging.

Wang T, Wu KY, Miner RC, Renaud JM, Beanlands RSB, deKemp RA.

EJNMMI Res. 2018 Jul 20;8(1):63. doi: 10.1186/s13550-018-0421-5.

2.

Image-Guided Neurosurgery.

Miner RC.

J Med Imaging Radiat Sci. 2017 Dec;48(4):328-335. doi: 10.1016/j.jmir.2017.06.005. Epub 2017 Aug 24. Review.

PMID:
31047466
3.

Improving the Management of Vaso-Occlusive Episodes in the Pediatric Emergency Department.

Kavanagh PL, Sprinz PG, Wolfgang TL, Killius K, Champigny M, Sobota A, Dorfman D, Barry K, Miner R, Moses JM.

Pediatrics. 2015 Oct;136(4):e1016-25. doi: 10.1542/peds.2014-3470. Epub 2015 Sep 21.

4.

Cone-beam computed tomography transverse analyses. Part 2: Measures of performance.

Miner RM, Al Qabandi S, Rigali PH, Will LA.

Am J Orthod Dentofacial Orthop. 2015 Aug;148(2):253-63. doi: 10.1016/j.ajodo.2015.03.027.

PMID:
26232834
5.

Newly defined landmarks for a three-dimensionally based cephalometric analysis: a retrospective cone-beam computed tomography scan review.

Lee M, Kanavakis G, Miner RM.

Angle Orthod. 2015 Jan;85(1):3-10. doi: 10.2319/021814-120.1.

PMID:
24866835
6.

Cone-beam computed tomography transverse analysis. Part I: Normative data.

Miner RM, Al Qabandi S, Rigali PH, Will LA.

Am J Orthod Dentofacial Orthop. 2012 Sep;142(3):300-7. doi: 10.1016/j.ajodo.2012.04.014.

PMID:
22920695
7.

Factors Influencing Non-cardiac Side Effects of Dipyridamole When Used for Myocardial Perfusion Stress Testing.

Miner R.

J Med Imaging Radiat Sci. 2012 Mar;43(1):43-51. doi: 10.1016/j.jmir.2011.12.004. Epub 2012 Jan 24.

PMID:
31052020
8.

Community-based participatory development, implementation, and evaluation of a cancer screening educational intervention among American Indians in the Northern Plains.

Subrahmanian K, Petereit DG, Kanekar S, Burhansstipanov L, Esmond S, Miner R, Spotted Tail C, Guadagnolo BA.

J Cancer Educ. 2011 Sep;26(3):530-9. doi: 10.1007/s13187-011-0211-5.

9.

Comparison of dental and apical base arch forms in Class II Division 1 and Class I malocclusions.

Ball RL, Miner RM, Will LA, Arai K.

Am J Orthod Dentofacial Orthop. 2010 Jul;138(1):41-50. doi: 10.1016/j.ajodo.2008.11.026.

PMID:
20620832
10.

Comparison of the mandibular dental and basal arch forms in adults and children with Class I and Class II malocclusions.

Gupta D, Miner RM, Arai K, Will LA.

Am J Orthod Dentofacial Orthop. 2010 Jul;138(1):10.e1-8; discussion 10-1. doi: 10.1016/j.ajodo.2010.01.024.

PMID:
20620824
11.

Greenhouse gas and carbon profile of the u.s. Forest products industry value chain.

Heath LS, Maltby V, Miner R, Skog KE, Smith JE, Unwin J, Upton B.

Environ Sci Technol. 2010 May 15;44(10):3999-4005. doi: 10.1021/es902723x.

12.

Lunch date.

Miner RA.

Minn Med. 2008 Dec;91(12):56. No abstract available.

PMID:
19902623
13.

Accuracy and reliability of linear cephalometric measurements from cone-beam computed tomography scans of a dry human skull.

Berco M, Rigali PH Jr, Miner RM, DeLuca S, Anderson NK, Will LA.

Am J Orthod Dentofacial Orthop. 2009 Jul;136(1):17.e1-9; discussion 17-8. doi: 10.1016/j.ajodo.2008.08.021.

PMID:
19577142
14.

Mandibular arch form: the relationship between dental and basal anatomy.

Ronay V, Miner RM, Will LA, Arai K.

Am J Orthod Dentofacial Orthop. 2008 Sep;134(3):430-8. doi: 10.1016/j.ajodo.2006.10.040.

PMID:
18774089
15.

Establishing a patient navigator program to reduce cancer disparities in the American Indian communities of Western South Dakota: initial observations and results.

Petereit DG, Molloy K, Reiner ML, Helbig P, Cina K, Miner R, Spotted Tail C, Rost C, Conroy P, Roberts CR.

Cancer Control. 2008 Jul;15(3):254-9.

16.

The perception of children's computer-imaged facial profiles by patients, mothers and clinicians.

Miner RM, Anderson NK, Evans CA, Giddon DB.

Angle Orthod. 2007 Nov;77(6):1034-9.

PMID:
18004912
17.

Missed appointments.

Miner R.

Minn Med. 2006 Dec;89(12):44-5. No abstract available.

PMID:
17256383
18.

Maribavir sensitivity of cytomegalovirus isolates resistant to ganciclovir, cidofovir or foscarnet.

Drew WL, Miner RC, Marousek GI, Chou S.

J Clin Virol. 2006 Oct;37(2):124-7. Epub 2006 Sep 8.

PMID:
16962820
19.

Not paid to talk.

Miner RA.

Minn Med. 2006 Apr;89(4):64. No abstract available.

PMID:
16681285
20.

Transverse skeletal and dental asymmetry in adults with unilateral lingual posterior crossbite.

Langberg BJ, Arai K, Miner RM.

Am J Orthod Dentofacial Orthop. 2005 Jan;127(1):6-15; discussion 15-6.

PMID:
15643408
21.

Id1 gene expression is up-regulated in hyperplastic and neoplastic thyroid tissue and regulates growth and differentiation in thyroid cancer cells.

Kebebew E, Peng M, Treseler PA, Clark OH, Duh QY, Ginzinger D, Miner R.

J Clin Endocrinol Metab. 2004 Dec;89(12):6105-11.

PMID:
15579766
22.

Absence of activation of CMV by blood transfusion to HIV-infected, CMV-seropositive patients.

Drew WL, Chou S, Mohr BA, Assmann SF, Miner RC, Laycock ME, Busch MP; Viral Activation Transfusion Study Group.

Transfusion. 2003 Oct;43(10):1351-7.

PMID:
14507264
23.

Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus.

Chou S, Lurain NS, Thompson KD, Miner RC, Drew WL.

J Infect Dis. 2003 Jul 1;188(1):32-9. Epub 2003 Jun 16. Erratum in: J Infect Dis. 2004 Sep 15;190(6):1202.

PMID:
12825168
24.

Frequency and duration of plasma CMV viremia in seroconverting blood donors and recipients.

Drew WL, Tegtmeier G, Alter HJ, Laycock ME, Miner RC, Busch MP.

Transfusion. 2003 Mar;43(3):309-13.

PMID:
12675714
25.

Thinking about things not thought of. Why it is important to volunteer and thank those who do.

Miner RD.

J N J Dent Assoc. 2002 Fall;73(4):34-5. No abstract available.

PMID:
12641038
26.
27.

Phase I dose escalation trial evaluating the pharmacokinetics, anti-human cytomegalovirus (HCMV) activity, and safety of 1263W94 in human immunodeficiency virus-infected men with asymptomatic HCMV shedding.

Lalezari JP, Aberg JA, Wang LH, Wire MB, Miner R, Snowden W, Talarico CL, Shaw S, Jacobson MA, Drew WL.

Antimicrob Agents Chemother. 2002 Sep;46(9):2969-76.

28.

Cytomegalovirus glycoprotein B groups in human immunodeficiency virus-infected patients with incident retinitis.

Drew WL, Chou S, Miner RC, Mohr BA, Busch MP, van der Horst CM, Asmuth DM, Kalish LA.

J Infect Dis. 2002 Jul 1;186(1):114-7. Epub 2002 May 22.

PMID:
12089671
29.
30.

Thoughts on setting up an ethics program.

Miner RD.

Ann Dent. 2001 Dec;5(1):5, 19-21. No abstract available.

PMID:
11890043
31.

Cytomegalovirus UL97 phosphotransferase mutations that affect susceptibility to ganciclovir.

Chou S, Waldemer RH, Senters AE, Michels KS, Kemble GW, Miner RC, Drew WL.

J Infect Dis. 2002 Jan 15;185(2):162-9. Epub 2001 Dec 17.

PMID:
11807689
32.

Variations in the cytomegalovirus DNA polymerase and phosphotransferase genes in relation to foscarnet and ganciclovir sensitivity.

Mousavi-Jazi M, Schloss L, Drew WL, Linde A, Miner RC, Harmenberg J, Wahren B, Brytting M.

J Clin Virol. 2001 Dec;23(1-2):1-15.

PMID:
11595579
33.

Antiviral activity and ocular kinetics of antisense oligonucleotides designed to inhibit CMV replication.

Henry SP, Miner RC, Drew WL, Fitchett J, York-Defalco C, Rapp LM, Levin AA.

Invest Ophthalmol Vis Sci. 2001 Oct;42(11):2646-51.

PMID:
11581212
34.

Presidential address. Strands of history.

Miner RD.

Ann Dent. 2000 Oct;4(1):1, 16-7. No abstract available.

PMID:
11432102
35.

Immune thrombocytopenic purpura, profuse diarrhea, and new onset ulcerative colitis: a dramatic response to splenectomy.

Miner RJ, Skoog SM.

J Clin Gastroenterol. 2001 Mar;32(3):276-7. No abstract available.

PMID:
11246367
36.
37.

A deletion mutation in region V of the cytomegalovirus DNA polymerase sequence confers multidrug resistance.

Chou S, Miner RC, Drew WL.

J Infect Dis. 2000 Dec;182(6):1765-8. Epub 2000 Oct 17.

PMID:
11069251
38.

A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates.

Landry ML, Stanat S, Biron K, Brambilla D, Britt W, Jokela J, Chou S, Drew WL, Erice A, Gilliam B, Lurain N, Manischewitz J, Miner R, Nokta M, Reichelderfer P, Spector S, Weinberg A, Yen-Lieberman B, Crumpacker C.

Antimicrob Agents Chemother. 2000 Mar;44(3):688-92.

39.

Decrease of cytomegalovirus replication in human immunodeficiency virus infected-patients after treatment with highly active antiretroviral therapy.

O'Sullivan CE, Drew WL, McMullen DJ, Miner R, Lee JY, Kaslow RA, Lazar JG, Saag MS.

J Infect Dis. 1999 Sep;180(3):847-9.

PMID:
10438377
40.

Cytomegalovirus (CMV) resistance in patients with CMV retinitis and AIDS treated with oral or intravenous ganciclovir.

Drew WL, Stempien MJ, Andrews J, Shadman A, Tan SJ, Miner R, Buhles W.

J Infect Dis. 1999 Jun;179(6):1352-5.

PMID:
10228054
41.

In vitro antiviral susceptibilities of isolates from cytomegalovirus retinitis patients receiving first- or second-line cidofovir therapy: relationship to clinical outcome.

Cherrington JM, Fuller MD, Lamy PD, Miner R, Lalezari JP, Nuessle S, Drew WL.

J Infect Dis. 1998 Dec;178(6):1821-5.

PMID:
9815243
42.
43.

Mutation in region III of the DNA polymerase gene conferring foscarnet resistance in cytomegalovirus isolates from 3 subjects receiving prolonged antiviral therapy.

Chou S, Marousek G, Parenti DM, Gordon SM, LaVoy AG, Ross JG, Miner RC, Drew WL.

J Infect Dis. 1998 Aug;178(2):526-30.

PMID:
9697736
44.

Academy helps budding colleagues through ethics program.

Miner RD.

Ann Dent. 1997 Oct:2, 5, 8. No abstract available.

PMID:
9403082
45.

Quantification of cytomegalovirus DNA in peripheral blood leukocytes by a branched-DNA signal amplification assay.

Chernoff DN, Miner RC, Hoo BS, Shen LP, Kelso RJ, Jekic-McMullen D, Lalezari JP, Chou S, Drew WL, Kolberg JA.

J Clin Microbiol. 1997 Nov;35(11):2740-4.

46.

Evolution of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease.

Chou S, Marousek G, Guentzel S, Follansbee SE, Poscher ME, Lalezari JP, Miner RC, Drew WL.

J Infect Dis. 1997 Sep;176(3):786-9.

PMID:
9291334
47.

Diagnosis of cytomegalovirus (CMV) polyradiculopathy and documentation of in vivo anti-CMV activity in cerebrospinal fluid by using branched DNA signal amplification and antigen assays.

Flood J, Drew WL, Miner R, Jekic-McMullen D, Shen LP, Kolberg J, Garvey J, Follansbee S, Poscher M.

J Infect Dis. 1997 Aug;176(2):348-52.

PMID:
9237699
48.

Cytomegalovirus gB genotype distribution differs in human immunodeficiency virus-infected patients and immunocompromised allograft recipients.

Rasmussen L, Hong C, Zipeto D, Morris S, Sherman D, Chou S, Miner R, Drew WL, Wolitz R, Dowling A, Warford A, Merigan TC.

J Infect Dis. 1997 Jan;175(1):179-84.

PMID:
8985216
49.

Characterization of the tumor invasion area in the rat intracerebral glioma.

Ji Y, Powers SK, Brown JT, Miner R.

J Neurooncol. 1996 Dec;30(3):189-97.

PMID:
8943094
50.

Receptor for interleukin (IL) 13 does not interact with IL4 but receptor for IL4 interacts with IL13 on human glioma cells.

Debinski W, Miner R, Leland P, Obiri NI, Puri RK.

J Biol Chem. 1996 Sep 13;271(37):22428-33.

Supplemental Content

Support Center